Abbott Showcases Next-Generation Alinity Family of Systems at AACC 2020 Virtual Event

Attendees to Abbott’s virtual booth experienced the company’s Alinity ci-series integrated clinical chemistry and immunoassay system, the Alinity h-series integrated hematology system and the Alinity m molecular system.

The Alinity series helps to easily adapt to the unpredictability of changing laboratory volume with scalable systems and multiple track connectivity options across Alinity platforms. The flexible, scalable systems allow easy addition of modules as lab volume grows over time, without having to replace any system. And with open automation and IT connectivity options such as Instrument Manager and AlinIQ BIS, a personalized solution can be designed for the entire laboratory. All this helps labs respond to the changing needs of the market and the community.

Alinity leverages powerful technology to redefine and improve operational productivity in the laboratory. Alinity allows users to more efficiently and effectively address limited space and increasing demand in their laboratory. Alinity has been designed to maximize the throughput in a more compact footprint. Additionally, Alinity allows staff more walkaway time, so they can focus on other critical tasks.

Alinity helps labs continually provide consistent, high-quality service and results through error-proof design elements and proven technology that minimize the frustration of repeat testing, system downtime, and medical errors. Additionally, labs can rely on Abbott’s high-quality assays with proven technology harmonized to CLSI guidelines, ensuring clear performance parameter definitions. And with predictive system monitoring through AlinIQ Always On, Abbott’s professional services can proactively monitor the health of the systems and help labs avoid unexpected downtime.